Annual Shareholders Equity
-$8.80 M
+$56.41 M+86.50%
December 31, 2024
Summary
- As of March 12, 2025, URGN annual stockholders equity is -$8.80 million, with the most recent change of +$56.41 million (+86.50%) on December 31, 2024.
- During the last 3 years, URGN annual shareholders equity has fallen by -$17.22 million (-204.64%).
- URGN annual shareholders equity is now -104.88% below its all-time high of $180.30 million, reached on December 31, 2019.
Performance
URGN Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
-$8.80 M
-$34.32 M-134.50%
December 1, 2024
Summary
- As of March 12, 2025, URGN quarterly stockholders equity is -$8.80 million, with the most recent change of -$34.32 million (-134.50%) on December 1, 2024.
- Over the past year, URGN quarterly shareholders equity has dropped by -$34.32 million (-134.50%).
- URGN quarterly shareholders equity is now -103.67% below its all-time high of $239.59 million, reached on March 31, 2019.
Performance
URGN Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
URGN Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +86.5% | -134.5% |
| 3 y3 years | -204.6% | -204.6% |
| 5 y5 years | -104.9% | -104.9% |
URGN Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -204.6% | +90.2% | -129.0% | +93.6% |
| 5 y | 5-year | -104.9% | +90.2% | -104.9% | +93.6% |
| alltime | all time | -104.9% | +90.2% | -103.7% | +93.6% |
UroGen Pharma Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | -$8.80 M(-86.5%) | - |
| Dec 2024 | - | -$8.80 M(-134.5%) |
| Sep 2024 | - | $25.52 M(-15.8%) |
| Jun 2024 | - | $30.31 M(-175.5%) |
| Mar 2024 | - | -$40.13 M(-38.5%) |
| Dec 2023 | -$65.21 M(-27.0%) | -$65.21 M(+55.3%) |
| Sep 2023 | - | -$41.99 M(-69.7%) |
| Jun 2023 | - | -$138.43 M(+18.8%) |
| Mar 2023 | - | -$116.55 M(+30.4%) |
| Dec 2022 | -$89.36 M(-1162.2%) | -$89.36 M(+41.2%) |
| Sep 2022 | - | -$63.29 M(+54.7%) |
| Jun 2022 | - | -$40.91 M(+139.6%) |
| Mar 2022 | - | -$17.07 M(-302.9%) |
| Dec 2021 | $8.41 M(-91.3%) | $8.41 M(-73.3%) |
| Sep 2021 | - | $31.54 M(-44.0%) |
| Jun 2021 | - | $56.27 M(-26.4%) |
| Mar 2021 | - | $76.49 M(-20.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2020 | $96.36 M(-46.6%) | $96.36 M(-20.1%) |
| Sep 2020 | - | $120.53 M(-15.5%) |
| Jun 2020 | - | $142.66 M(-5.2%) |
| Mar 2020 | - | $150.45 M(-16.6%) |
| Dec 2019 | $180.30 M(+100.1%) | $180.30 M(-14.5%) |
| Sep 2019 | - | $210.92 M(-6.2%) |
| Jun 2019 | - | $224.78 M(-6.2%) |
| Mar 2019 | - | $239.59 M(+165.9%) |
| Dec 2018 | $90.09 M(+31.5%) | $90.09 M(-13.0%) |
| Sep 2018 | - | $103.58 M(-8.8%) |
| Jun 2018 | - | $113.55 M(-8.3%) |
| Mar 2018 | - | $123.87 M(+80.8%) |
| Dec 2017 | $68.52 M(+320.2%) | $68.52 M(-10.2%) |
| Sep 2017 | - | $76.26 M(+3.0%) |
| Jun 2017 | - | $74.07 M(+354.2%) |
| Dec 2016 | $16.31 M(+0.2%) | $16.31 M |
| Dec 2015 | $16.28 M | - |
FAQ
- What is UroGen Pharma annual stockholders equity?
- What is the all time high annual shareholders equity for UroGen Pharma?
- What is UroGen Pharma annual shareholders equity year-on-year change?
- What is UroGen Pharma quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for UroGen Pharma?
- What is UroGen Pharma quarterly shareholders equity year-on-year change?
What is UroGen Pharma annual stockholders equity?
The current annual shareholders equity of URGN is -$8.80 M
What is the all time high annual shareholders equity for UroGen Pharma?
UroGen Pharma all-time high annual stockholders equity is $180.30 M
What is UroGen Pharma annual shareholders equity year-on-year change?
Over the past year, URGN annual stockholders equity has changed by +$56.41 M (+86.50%)
What is UroGen Pharma quarterly stockholders equity?
The current quarterly shareholders equity of URGN is -$8.80 M
What is the all time high quarterly shareholders equity for UroGen Pharma?
UroGen Pharma all-time high quarterly stockholders equity is $239.59 M
What is UroGen Pharma quarterly shareholders equity year-on-year change?
Over the past year, URGN quarterly stockholders equity has changed by -$34.32 M (-134.50%)